DRI Healthcare Trust (TSX:DHT.U) Debt-to-Asset : 0.26 (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is DRI Healthcare Trust Debt-to-Asset?

DRI Healthcare Trust's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was $0.0 Mil. DRI Healthcare Trust's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was $231.3 Mil. DRI Healthcare Trust's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Sep. 2024 was $884.1 Mil. DRI Healthcare Trust's debt to asset for the quarter that ended in Sep. 2024 was 0.26.

DRI Healthcare Trust Debt-to-Asset Historical Data

The historical data trend for DRI Healthcare Trust's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DRI Healthcare Trust Debt-to-Asset Chart

DRI Healthcare Trust Annual Data

Trend

Dec21

Dec22

Dec23

Debt-to-Asset

0.10

0.39

0.17

DRI Healthcare Trust Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Debt-to-Asset	Get a 7-Day Free Trial										0.18	0.17	0.26	0.26	0.26

Competitive Comparison of DRI Healthcare Trust's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, DRI Healthcare Trust's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DRI Healthcare Trust's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, DRI Healthcare Trust's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where DRI Healthcare Trust's Debt-to-Asset falls into.

DRI Healthcare Trust Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

DRI Healthcare Trust's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0	+	145.478)	/	834.957
	=	0.17

DRI Healthcare Trust's Debt-to-Asset for the quarter that ended in Sep. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0	+	231.299)	/	884.079
	=	0.26

DRI Healthcare Trust (TSX:DHT.U) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

DRI Healthcare Trust Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of DRI Healthcare Trust's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

DRI Healthcare Trust Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » DRI Healthcare Trust (TSX:DHT.U) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

DHTRF:USA DHT.UN:Canada

Address

100 King Street West, 1 First Canadian Place, Suite 7250, Toronto, ON, CAN, M5X 1B1

Website

https://www.dricapital.com

DRI Healthcare Trust is engaged in pharmaceutical royalty monetization by providing capital to inventors, academic institutions, and biopharma companies. Trust was formed to provide Unitholders with differential exposure to the pharmaceutical and biotechnology industries through ownership and acquisitions of pharmaceutical royalties. In return for providing capital to biopharmaceutical innovators, the company is building a diversified portfolio of interests in medicines that have a demonstrable positive impact on the world. The Trust has concluded that it operates as one segment, primarily focused on acquiring royalty assets. Geographically the trust generates major revenue from the United States. The trust also generates Income from markets such as Japan, and the European Union.

DRI Healthcare Trust Headlines

No Headlines